Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jun;20(3):640–645. doi: 10.1128/iai.20.3.640-645.1978

Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection.

S B Greenberg, B S Criswell, H R Six, R B Couch
PMCID: PMC421906  PMID: 669816

Abstract

Peripheral blood leukocytes obtained from volunteers at various times following influenza vaccine or live influenza virus infection were assayed for cytotoxicity against influenza virus-infected cells. Cytotoxicity was highest on days 3 and 7 following vaccination with commercial A/Port Chalmers/1/73 inactivated influenza virus vaccine. Maximal cytotoxicity was found 9 days after infection induced by intranasal inoculation of a strain of A/Scotland/840/74 influenza virus. Individuals naturally infected with A/Victoria/3/75 were also found to have elevated cytotoxicity approximately 1 week after onset of illness. Cytotoxicity levels decreased toward base line approximately 30 days after the virus exposure. The effector mechanism(s) responsible for the early, transient elevation in specific immune release to influenza virus-infected cells may be different from the antibody-dependent cell cytotoxicity demonstrated in the peripheral blood leukocytes from volunteers who had a remote experience with influenza virus.

Full text

PDF
640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cambridge G., Mackenzie J. S., Keast D. Cell-mediated immune response to influenza virus infections in mice. Infect Immun. 1976 Jan;13(1):36–43. doi: 10.1128/iai.13.1.36-43.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Fazio S. R., Criswell B. S., Kimzey S. L., South M. A., Montgomery J. R. A paraprotein in severe combined immunodefeciency disease detected by immunoelectrophoretic analysis of plasma. Clin Exp Immunol. 1975 Mar;19(3):563–570. [PMC free article] [PubMed] [Google Scholar]
  3. Doherty P. C., Blanden R. V., Zinkernagel R. M. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev. 1976;29:89–124. doi: 10.1111/j.1600-065x.1976.tb00198.x. [DOI] [PubMed] [Google Scholar]
  4. Dolin R., Richman D. D., Murphy B. R., Fauci A. S. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis. 1977 May;135(5):714–719. doi: 10.1093/infdis/135.5.714. [DOI] [PubMed] [Google Scholar]
  5. Golstein P., Blomgren H. Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells. Cell Immunol. 1973 Oct;9(1):127–141. doi: 10.1016/0008-8749(73)90174-3. [DOI] [PubMed] [Google Scholar]
  6. Greenberg S. B., Criswell B. S., Couch R. B. Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method. J Immunol. 1975 Aug;115(2):601–603. [PubMed] [Google Scholar]
  7. Greenberg S. B., Criswell B. S., Six H. R., Couch R. B. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes. J Immunol. 1977 Dec;119(6):2100–2106. [PubMed] [Google Scholar]
  8. Jondal M., Wigzell H., Aiuti F. Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev. 1973;16:163–195. doi: 10.1111/j.1600-065x.1973.tb00120.x. [DOI] [PubMed] [Google Scholar]
  9. Jurgensen P. F., Olsen G. N., Johnson J. E., 3rd, Swenson E. W., Ayoub E. M., Henney C. S., Waldman R. H. Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis. 1973 Dec;128(6):730–735. doi: 10.1093/infdis/128.6.730. [DOI] [PubMed] [Google Scholar]
  10. KNIGHT V. THE USE OF VOLUNTEERS IN MEDICAL VIROLOGY. Prog Med Virol. 1964;6:1–26. [PubMed] [Google Scholar]
  11. Perrin L. H., Zinkernagel R. M., Oldstone M. B. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. J Exp Med. 1977 Oct 1;146(4):949–969. doi: 10.1084/jem.146.4.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rodda S. J., White D. O. Cytotoxic macrophages: a rapid nonspecific response to viral infection. J Immunol. 1976 Dec;117(6):2067–2072. [PubMed] [Google Scholar]
  13. Rola-Pleszczynski M., Hurtado R. C., Woody J. N., Sell K. W., Vincent M. M., Hensen S. A., Bellanti J. A. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol. 1975 Jul;115(1):239–242. [PubMed] [Google Scholar]
  14. Six H. R., Kasel J. A. Radioimmunoprecipitation assay for quantitation of serum antibody to the hemagglutinin of type A influenza virus. J Clin Microbiol. 1978 Feb;7(2):165–171. doi: 10.1128/jcm.7.2.165-171.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES